...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: The waiting game.....
5
Jan 11, 2019 11:09AM
2
Jan 11, 2019 01:16PM
3
Jan 11, 2019 01:35PM
5
Jan 15, 2019 11:18AM
4
Jan 15, 2019 12:16PM
4
Jan 17, 2019 10:31AM
1
Jan 17, 2019 11:37AM
3
Jan 17, 2019 11:45AM
2
Jan 17, 2019 01:23PM
1
Jan 17, 2019 01:57PM
5
Jan 23, 2019 10:41PM
2
Jan 24, 2019 09:37AM
3
Jan 24, 2019 09:52AM
6
Feb 04, 2019 11:34AM
2
Feb 04, 2019 12:03PM
3
Feb 04, 2019 12:48PM
2
Feb 04, 2019 03:21PM
2
Feb 04, 2019 03:27PM
2
Feb 04, 2019 04:23PM
1
Feb 04, 2019 04:25PM
1
Feb 12, 2019 02:38PM
1
Feb 12, 2019 02:56PM
2
Feb 12, 2019 03:02PM
3
Feb 12, 2019 03:35PM
3
Feb 12, 2019 03:46PM
2
Feb 12, 2019 04:08PM
2
Feb 12, 2019 04:12PM
2
Feb 12, 2019 04:22PM
2
Feb 12, 2019 05:09PM
3
Feb 12, 2019 05:53PM
3
Feb 12, 2019 06:23PM
5
Feb 12, 2019 06:39PM
3
Feb 12, 2019 07:46PM
5
Feb 12, 2019 08:29PM
4
Feb 13, 2019 05:09AM
3
Feb 13, 2019 06:53AM
2
Feb 13, 2019 08:51AM
2
Feb 13, 2019 09:20AM

As has been pointed out, the fact that a portion of patients have been on drug for longer than 3 years and no safety concerns have been cited by the DSMB will speak well for Apabetalone if the trial is successful.

To me it is always a bit of a numbers crap shoot regarding patients in either test or placebo arms who have an event close to their initial enrolment in a trial. They are at highest risk due to a recent occurrence that qualifies them for trial participation and one wonders if those in the test arm have really been on drug long enough for the drug to have an opportunity for effect. Obviously I hope that top line data shows a large and significant RRR. What I hope even more is that the study will show that test arm patients show an increasing RRR with time on drug as compared to their same time in study placebo counterparts. To me this is the true test as to the effect of a chronic care drug. JMO

Share
New Message
Please login to post a reply